Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2006

May 4, 2006

30339_dirs_2006-05-04_dd840f97-7e24-49fb-8fc5-956c544a1184.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-05-02

Reporting Person: Johnson Paula A (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-05-02 Phantom Stock Unit $ A 2000 Acquired Common Stock (2000.00) Direct
2006-05-02 Stock Option (Right to Buy) $36.1000 A 6400 Acquired 2016-05-02 Common Stock (6400.00) Direct

Footnotes

F1: Awards of phantom stock units are to be settled only in cash upon the reporting person's termination as a director.

F2: Reflects addtional Phantom Stock Units credited through dividend reinvestment based on most recent plan statement.